Katie Wright, Author at European Medical Journal - Page 16 of 45

AI Digital Twins Personalise Chemo Dosing, Reducing Drug Use by 20%

A new AI platform cuts chemo doses by 20% using personalised digital twins in cancer trials.

Early B-Cell Profiles May Predict Remission in Rheumatoid Arthritis

Transitional and CD21⁻ PD-1⁺ B cells identified at diagnosis were linked to better treatment outcomes in early rheumatoid arthritis, according to a spin-off analysis of the NORD-STAR trial.

Hormonal IUDs Linked to Higher Rosacea Risk in Women

A new study reveals a potential link between certain hormonal IUDs and the onset of rosacea, with dermatologists urging awareness of symptoms and treatment options.

Shorter All-Oral TB Regimens Boost Success in Drug-Resistant Cases

Shorter, all-oral bedaquiline-based regimens show 83% success in drug-resistant TB, cutting risk of death and failure.

Dual Index Approach Enhances Detection of Functional Decline in Patients on Haemodialysis

A new study highlights how combining the Geriatric Nutritional Risk Index (GNRI) and Modified Creatinine Index (mCI) significantly improves prediction of functional dependence in hemodialysis patients.

New Emulsion Outperforms Petrolatum in Childhood Eczema

Results revealed that the group using partially myristoylated carboxymethyl chitosan emulsion experienced a significantly greater reduction in EASI scores.

Stockholm3: A Breakthrough in Prostate Cancer Screening

In comparison with other established biomarkers, such as the free/total PSA ratio and PSA density, Stockholm3 outperformed these tests.

Childhood Thyroid Cancer Risk Linked to Pollution and Night-time Light

New study links early-life air pollution and night-time light exposure to increased risk of paediatric thyroid cancer.

Majority Support AI-Assisted Mammograms, But Few Trust It Alone

Most women support AI in mammography if radiologists remain involved, with education and race influencing acceptance levels.

Young Stroke Survivors: Who Is Most at Risk for Poststroke Epilepsy?

Young adults face a low but notable risk of epilepsy after stroke, with risk factors well-predicted by current scores.